Regulatory

>

Latest News

FDA, CDC Recommend Pause on Valneva's Chikungunya Vaccine for Seniors
FDA, CDC Recommend Pause on Valneva's Chikungunya Vaccine for Seniors

May 14th 2025

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who received the Ixchiq chikungunya vaccine.

President Donald Trump
Pharma Organizations Respond to Trump’s Most-Favored-Nation Policy

May 13th 2025

Stock.adobe.com
White House Unveils Pharma Most-Favored-Nation Executive Order

May 12th 2025

Donald Trump
President Trump Announces Most-Favored-Nation Policy for Pharma Prices

May 12th 2025

Marcel Botha
The Risk to Rural Health Networks: Q&A with Marcel Botha

May 12th 2025

More News